Clinical Trial Update: R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating R-(-)-Gossypol in combination with androgen ablation for newly diagnosed metastatic prostate cancer has completed. Results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen Ablation Therapy
• R-(-)-Gossypol

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Stage IV Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-18